Quest Diagnostics Incorporated (DGX) — Fair Value Analysis

Base-case fair value (P50): $185.74 · Current price: $190.89 · Verdict: Fairly Valued

The Verdict on DGX

Quest Diagnostics (DGX), a key player in the Healthcare sector, currently trades at $190.89. Our Monte Carlo simulations, running thousands of forward-looking scenarios, indicate a median fair value (P50) of $185.74. This suggests a -2.7% difference against the current market price, leading us to classify DGX as Fairly Valued. While not presenting an immediate, significant discount or premium, this close alignment between the market and our probabilistic models signals that DGX's current valuation reflects its intrinsic worth within the prevailing Healthcare landscape, based on our comprehensive analysis.

How DGX stacks up against Healthcare

When evaluating DGX against its Healthcare sector peers, our quality tier assessment pegs the company as average in terms of operational and financial health. This implies that while DGX demonstrates solid fundamentals, it doesn't significantly outperform or underperform its industry benchmarks. The $190.89 valuation, positioned closely to our $185.74 median fair value, reflects this average quality tier. An average rating suggests that investors are pricing in DGX's consistent performance without assigning a substantial premium for exceptional strength or a discount for notable weaknesses. This equilibrium is central to its Fairly Valued assessment.

What this means for investors

For investors considering Quest Diagnostics, the Fairly Valued verdict, stemming from a -2.7% differential between its current trading price of $190.89 and our $185.74 median fair value, points to a balanced risk/reward profile. This close alignment, supported by DGX's average operational and financial health within the Healthcare sector, suggests that the market is appropriately valuing the company based on current information and our probabilistic models. While this doesn't preclude future price movements, our Monte Carlo analysis implies that the intrinsic value is well-reflected. A significant divergence from the $185.74 would signal a potential arbitrage opportunity or a fundamental re-evaluation by the market. FairCurve's detailed simulations provide a robust framework for understanding these dynamics, offering insights beyond simple multiples. To fully understand the range of potential outcomes, including the specific bear and bull case scenarios and the precise probability of upside, sign up for FairCurve to see the full bear/bull distribution and track DGX's fair value as new fundamentals are released.